Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban for Painful Venous Malformations with LIC
NCT06729034Phase 2Not yet recruiting
- Sponsor
- Oslo University Hospital
- Start
- Feb 2025
- Primary completion
- Dec 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of apixaban in venous malformations (VM), sponsored by Oslo University Hospital. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
apixaban
03
Conditions
venous malformations (VM)
Beyond the preview
Go deeper on NCT06729034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06729034.